Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Apr;80(1-2):249–255. doi: 10.1038/sj.bjc.6690347

Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection

K D Jacobsen 1, S Ous 2, H Wæhre 2, H Trasti 2, A E Stenwig 3, H H Lien 4, N Aass 1, S D Fosså 1
PMCID: PMC2363017  PMID: 10390004

Abstract

The purpose of this study was to evaluate fertility after different types of post-chemotherapy retroperitoneal lymph node dissection (RPLND). During 1980–1994, 192 patients with metastatic testicular cancer underwent post-chemotherapy RPLND with a gradual shift from modified bilateral template RPLND to nerve-sparing RPLND. Modified bilateral template RPLND was done in 92% of the patients operated during 1980–1984 as compared to 16% during 1989–1994. Pre- and post-treatment fertility was assessed by microscopic sperm analysis, determination of serum FSH and information on ejaculation and paternity. There was no significant difference of the survival rates between the three treatment periods. Antegrade ejaculation was preserved in 11% of the patients after modified bilateral template RPLND as compared to 89% after the nerve-sparing operation technique. The median ejaculatory volume decreased post-operatively, serum FSH increased and sperm density remained unchanged. Fifty-six patients attempted fatherhood after their treatment, and 27 fathered at least one child after an observation-time of 55 months, nine of them by assisted fertilization. Patients with initially advanced testicular cancer but limited residual retroperitoneal masses after induction chemotherapy can safely undergo limited post-chemotherapy RPLND as a part of multimodality treatment. After nerve-sparing RPLND antegrade ejaculation is preserved in 89% of the patients though the ejaculatory volume decreases after RPLND. Post-treatment fatherhood can be achieved in at least 50% of the patients attempting paternity. © 1999 Cancer Research Campaign

Keywords: testicular cancer, nerve-sparing RPLND, fertility

Full Text

The Full Text of this article is available as a PDF (143.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aass N., Fosså S. D., Aas M., Lindegaard M. W. Renal function related to different treatment modalities for malignant germ cell tumours. Br J Cancer. 1990 Nov;62(5):842–846. doi: 10.1038/bjc.1990.391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aass N., Fosså S. D. Paternity in young patients with testicular cancer--expectations and experience. Prog Clin Biol Res. 1988;269:481–491. [PubMed] [Google Scholar]
  3. Aass N., Fosså S. D., Theodorsen L., Norman N. Prediction of long-term gonadal toxicity after standard treatment for testicular cancer. Eur J Cancer. 1991;27(9):1087–1091. doi: 10.1016/0277-5379(91)90298-r. [DOI] [PubMed] [Google Scholar]
  4. Bajorin D. F., Sarosdy M. F., Pfister D. G., Mazumdar M., Motzer R. J., Scher H. I., Geller N. L., Fair W. R., Herr H., Sogani P. Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study. J Clin Oncol. 1993 Apr;11(4):598–606. doi: 10.1200/JCO.1993.11.4.598. [DOI] [PubMed] [Google Scholar]
  5. Berthelsen J. G. Sperm counts and serum follicle-stimulating hormone levels before and after radiotherapy and chemotherapy in men with testicular germ cell cancer. Fertil Steril. 1984 Feb;41(2):281–286. doi: 10.1016/s0015-0282(16)47605-3. [DOI] [PubMed] [Google Scholar]
  6. Bissett D., Kunkeler L., Zwanenburg L., Paul J., Gray C., Swan I. R., Kerr D. J., Kaye S. B. Long-term sequelae of treatment for testicular germ cell tumours. Br J Cancer. 1990 Oct;62(4):655–659. doi: 10.1038/bjc.1990.350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bosl G. J., Motzer R. J. Testicular germ-cell cancer. N Engl J Med. 1997 Jul 24;337(4):242–253. doi: 10.1056/NEJM199707243370406. [DOI] [PubMed] [Google Scholar]
  8. Brenner J., Vugrin D., Whitmore W. F., Jr Effect of treatment on fertility and sexual function in males with metastatic nonseminomatous germ cell tumors of testis. Am J Clin Oncol. 1985 Apr;8(2):178–182. doi: 10.1097/00000421-198504000-00014. [DOI] [PubMed] [Google Scholar]
  9. Donohue J. P., Foster R. S., Rowland R. G., Bihrle R., Jones J., Geier G. Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol. 1990 Aug;144(2 Pt 1):287–292. doi: 10.1016/s0022-5347(17)39434-x. [DOI] [PubMed] [Google Scholar]
  10. Drasga R. E., Einhorn L. H., Williams S. D., Patel D. N., Stevens E. E. Fertility after chemotherapy for testicular cancer. J Clin Oncol. 1983 Mar;1(3):179–183. doi: 10.1200/JCO.1983.1.3.179. [DOI] [PubMed] [Google Scholar]
  11. Fosså S. D., Aass N., Kaalhus O. Testicular cancer in young Norwegians. J Surg Oncol. 1988 Sep;39(1):43–63. doi: 10.1002/jso.2930390110. [DOI] [PubMed] [Google Scholar]
  12. Fosså S. D., Aass N., Ous S., Waehre H. Long-term morbidity and quality of life in testicular cancer patients. Scand J Urol Nephrol Suppl. 1991;138:241–246. [PubMed] [Google Scholar]
  13. Fosså S. D., Borge L., Aass N., Johannessen N. B., Stenwig A. E., Kaalhus O. The treatment of advanced metastatic seminoma: experience in 55 cases. J Clin Oncol. 1987 Jul;5(7):1071–1077. doi: 10.1200/JCO.1987.5.7.1071. [DOI] [PubMed] [Google Scholar]
  14. Fosså S. D., Klepp O., Ous S., Lien H. H., Stenwig A. E., Abyholm T., Kaalhus O. Unilateral retroperitoneal lymph node dissection in patients with non-seminomatous testicular tumor in clinical stage I. Eur Urol. 1984;10(1):17–23. doi: 10.1159/000463504. [DOI] [PubMed] [Google Scholar]
  15. Fosså S. D., Klepp O., Ous S., Lien H., Stenwig J. T., Abeler V., Eliassen G., Høst H. Multi-modality treatment in males with advanced malignant germ cell tumours. II. Experience with surgery and radiotherapy following cis-platinum-based chemotherapy. Scand J Urol Nephrol. 1984;18(1):21–26. doi: 10.3109/00365598409182159. [DOI] [PubMed] [Google Scholar]
  16. Fosså S. D., Ous S., Abyholm T., Loeb M. Post-treatment fertility in patients with testicular cancer. I. Influence of retroperitoneal lymph node dissection on ejaculatory potency. Br J Urol. 1985 Apr;57(2):204–209. doi: 10.1111/j.1464-410x.1985.tb06425.x. [DOI] [PubMed] [Google Scholar]
  17. Fosså S. D., Ous S., Abyholm T., Norman N., Loeb M. Post-treatment fertility in patients with testicular cancer. II. Influence of cis-platin-based combination chemotherapy and of retroperitoneal surgery on hormone and sperm cell production. Br J Urol. 1985 Apr;57(2):210–214. doi: 10.1111/j.1464-410x.1985.tb06426.x. [DOI] [PubMed] [Google Scholar]
  18. Fosså S. D., Qvist H., Stenwig A. E., Lien H. H., Ous S., Giercksky K. E. Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses? J Clin Oncol. 1992 Apr;10(4):569–573. doi: 10.1200/JCO.1992.10.4.569. [DOI] [PubMed] [Google Scholar]
  19. Hendry W. F., A'Hern R. P., Hetherington J. W., Peckham M. J., Dearnaley D. P., Horwich A. Para-aortic lymphadenectomy after chemotherapy for metastatic non-seminomatous germ cell tumours: prognostic value and therapeutic benefit. Br J Urol. 1993 Feb;71(2):208–213. doi: 10.1111/j.1464-410x.1993.tb15920.x. [DOI] [PubMed] [Google Scholar]
  20. Hermanek P., Sigel A. Necessary extent of lymph node dissection in testicular tumours. A histopathological investigation. Eur Urol. 1982;8(3):135–144. doi: 10.1159/000473500. [DOI] [PubMed] [Google Scholar]
  21. Hollender A., Stenwig E. A., Ous S., Fosså S. D. Survival of patients with viable malignant non-seminomatous germ cell tumour persistent after cisplatin-based induction chemotherapy. Eur Urol. 1997;31(2):141–147. doi: 10.1159/000474439. [DOI] [PubMed] [Google Scholar]
  22. Jewett M. A., Kong Y. S., Goldberg S. D., Sturgeon J. F., Thomas G. M., Alison R. E., Gospodarowicz M. K. Retroperitoneal lymphadenectomy for testis tumor with nerve sparing for ejaculation. J Urol. 1988 Jun;139(6):1220–1224. doi: 10.1016/s0022-5347(17)42869-2. [DOI] [PubMed] [Google Scholar]
  23. Lampe H., Horwich A., Norman A., Nicholls J., Dearnaley D. P. Fertility after chemotherapy for testicular germ cell cancers. J Clin Oncol. 1997 Jan;15(1):239–245. doi: 10.1200/JCO.1997.15.1.239. [DOI] [PubMed] [Google Scholar]
  24. Lange P. H., Chang W. Y., Fraley E. E. Fertility issues in the therapy of nonseminomatous testicular tumors. Urol Clin North Am. 1987 Nov;14(4):731–747. [PubMed] [Google Scholar]
  25. Lange P. H., Narayan P., Fraley E. E. Fertility issues following therapy for testicular cancer. Semin Urol. 1984 Nov;2(4):264–274. [PubMed] [Google Scholar]
  26. Loehrer P. J., Sr Ifosfamide in testicular cancer. Semin Oncol. 1990 Apr;17(2 Suppl 4):2–5. [PubMed] [Google Scholar]
  27. Moynihan C. Testicular cancer: the psychosocial problems of patients and their relatives. Cancer Surv. 1987;6(3):477–510. [PubMed] [Google Scholar]
  28. Narayan P., Lange P. H., Fraley E. E. Ejaculation and fertility after extended retroperitoneal lymph node dissection for testicular cancer. J Urol. 1982 Apr;127(4):685–688. doi: 10.1016/s0022-5347(17)53996-8. [DOI] [PubMed] [Google Scholar]
  29. Pizzocaro G., Salvioni R., Zanoni F. Unilateral lymphadenectomy in intraoperative stage I nonseminomatous germinal testis cancer. J Urol. 1985 Sep;134(3):485–489. doi: 10.1016/s0022-5347(17)47252-1. [DOI] [PubMed] [Google Scholar]
  30. Roth B. J., Greist A., Kubilis P. S., Williams S. D., Einhorn L. H. Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long-term follow-up. J Clin Oncol. 1988 Aug;6(8):1239–1247. doi: 10.1200/JCO.1988.6.8.1239. [DOI] [PubMed] [Google Scholar]
  31. Weissbach L., Boedefeld E. A., Oberdörster W. Modified RLND as a means to preserve ejaculation. Prog Clin Biol Res. 1985;203:323–334. [PubMed] [Google Scholar]
  32. Whitmore W. F., Jr Surgical treatment of adult germinal testis tumors. Semin Oncol. 1979 Mar;6(1):55–68. [PubMed] [Google Scholar]
  33. Whitmore W. F., Jr Surgical treatment of clinical stage I nonseminomatous germ gell tumors of the testis. Cancer Treat Rep. 1982 Jan;66(1):5–10. [PubMed] [Google Scholar]
  34. Wood D. P., Jr, Herr H. W., Heller G., Vlamis V., Sogani P. C., Motzer R. J., Fair W. R., Bosl G. J. Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors. J Urol. 1992 Dec;148(6):1812–1816. doi: 10.1016/s0022-5347(17)37036-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES